VBS
VECTUS BIOSYSTEMS LIMITED
$0.1050
0.00%
Market cap
$7M
Turnover
—
Last price
$0.1050
Day change
0.00%
Announcements
8
Range, past year
Open 0.074 · Low 0.037 · Now 0.105 · High 0.455
Open VBS in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
VBS momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-10-13.
Momentum quality
34/100
Wyckoff phase
Accumulation1d
Trend stage
Neutral
1 Day
+0.0%
1 Week
+5.0%
1 Month
+5.0%
1 Year
+41.9%
RSI
36
Avg daily range
8.4%
VECTUS BIOSYSTEMS LIMITED scores 34 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 1 trading day. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently outperforming and the institutional accumulation signal reads low.
What stands out
- Volume 1.9× 60-day avg
Points to watch
- 60d drawdown -45.9%
- High volatility (ATR 8.4%)
- Risk rating: Very High
- Composite downside risk elevated
VBS announcements
Recent price-sensitive releases.
- 2026-09-30 FDA Pre-IND Meeting Request Granted for VB0004 Progress Report
- 2026-08-31 Preliminary Final Report Preliminary Final Report
- 2026-05-22 Placement of Shares
- 2026-05-07 Appointment of Dr Tara Speranza as CEO & CTO
- 2026-04-30 Quarterly Activities & Appendix 4C Cash Flow Reports
More Health Care stocks
Most traded in the same sector.